ClearPoint Neuro, Inc. - SIC # 3844 - X-RAY APPARATUS AND TUBES AND RELATED IRRADIATION APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CLPT Nasdaq 3844 www.clearpointneuro.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ClearPoint Neuro, Inc.

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue - Jan 12th, 2026 6:30 am
What Creates a Long-Term Growth Opportunity for ClearPoint Neuro (CLPT)? - Dec 24th, 2025 5:38 am
Here’s What Boosted ClearPoint Neuro (CLPT) in Q3 - Dec 5th, 2025 8:01 am
ClearPoint Neuro Completes Acquisition of IRRAS - Nov 20th, 2025 3:00 pm
Despite currently being unprofitable, ClearPoint Neuro (NASDAQ:CLPT) has delivered a 66% return to shareholders over 5 years - Nov 14th, 2025 3:38 am
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2025 4:15 pm
ClearPoint Neuro Reports Third Quarter 2025 Results - Nov 6th, 2025 2:55 pm
ClearPoint Neuro Announces Agreement to Acquire IRRAS - Nov 6th, 2025 2:50 pm
Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates - Nov 5th, 2025 3:55 pm
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025 - Nov 5th, 2025 3:02 pm
Integra LifeSciences (IART) Q3 Earnings Beat Estimates - Oct 30th, 2025 5:10 am
TransMedics (TMDX) Beats Q3 Earnings Estimates - Oct 29th, 2025 3:35 pm
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles - Oct 7th, 2025 2:15 pm
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - Oct 6th, 2025 2:10 pm
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies - Oct 6th, 2025 6:04 am
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress - Oct 4th, 2025 7:57 am
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - Oct 1st, 2025 2:05 pm
Will ClearPoint Neuro's (CLPT) New CMO Shape Its Leadership in Cell and Gene Therapy? - Sep 27th, 2025 7:39 am
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer - Sep 25th, 2025 2:05 pm
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners - Sep 4th, 2025 2:05 pm